Roseline d’Oiron on The Challenges of Pregnancy and Childbirth in Glanzmann Thrombasthenia at EAHAD 2026
Haemophilia Journal shared on LinkedIn:
”Today at EAHAD 2026, Roseline d’Oiron highlighted the challenges of pregnancy and childbirth in women with Glanzmann Thrombasthenia.
A recent Haemophilia Journal paper by Karlijn Rutten, Roger Schutgens, Roseline d’Oiron et al. shared results from an European Association for Haemophilia and Allied Disorders (EAHAD) survey across 18 countries.
This survey illustrated how care for women with Glanzmann Thrombasthenia requires multidisciplinary planning and individualized management.
Check out the full paper”
Title: International Practices in Managing Preconception, Pregnancy and Childbirth in Women With Glanzmann Thrombasthenia: A Survey From the European Association of Haemophilia and Allied Disorders (EAHAD)
Authors: Karlijn H. G. Rutten; Roger E. G. Schutgens; Roseline d’Oiron; Mathieu Fiore; Giancarlo Castaman; Keith Gomez; Mary Mathias; Michelle Lavin; Petra Elfvinge; Rezan Abdul Kadir; Karin P. M. van Galen, the Glanzmann Thrombasthenia and Women and Girls with Bleeding Disorders Working Groups of the EAHAD
Read the Full Article on Haemophilia Journal
More from EAHAD 2026 featured in Hemostasis Today.
-
Mar 24, 2026, 17:12Ron DePinho: CRISPR Progress in Cellular Immunotherapy
-
Mar 24, 2026, 17:12Martine Gilard։ Women’s Heart Health as a National Priority
-
Mar 24, 2026, 17:11Erik Nelson։ Blood Vessels – The Silent System That Determines How You Age
-
Mar 24, 2026, 17:10Anthony Yazbeck: Why the Hemolysin Test Matters More Than You Think
-
Mar 24, 2026, 17:09Marcos Gamboa Chele: Are We Asking for Too Many Thrombophilia Panels?
-
Mar 24, 2026, 17:06Anita Brikman: PPTA Explores India’s Growing Plasma-Derived Medicines Industry
-
Mar 24, 2026, 17:01Victor Canata: Is Embolectomy the Best Treatment for Pulmonary Thromboembolism?
-
Mar 24, 2026, 16:57Hossam Qassem: The Stepwise Investigation Framework for ICU Hemoglobin Drop
-
Mar 24, 2026, 16:56Alan Nurden: Targeting Splice Site Variants in Alport Syndrome with Antisense Therapy